Events
Upcoming Events
Please check back for upcoming events.
Archived Events
Rodman & Renshaw Annual Global Investment Conference in New York City
Tuesday, November 11, 2008, 9:30 a.m. ET.
AVI BioPharma Third Quarter 2008 Financial Results Conference Call
November 10, 2008
AVI BioPharma Investor and Analyst Briefing: "Transitioning an Antisense Pioneer into a Leading RNA–based Drug Discovery and Development Company"
September 10, 2008
RNA–based drug discovery and development
Dr. Leslie Hudson, President and CEO, AVI BioPharma
Audio (MP3),
Slides (PDF)
Duchenne Muscular Dystrophy (DMD): The disease, its clinical management and future treatment
Professor Francesco Muntoni, Professor of Pediatric Neurology, Head of the Dubowitz Neuromuscular Centre, University College London Institute of Child Health, London, UK
Audio Part 1 (MP3),
Audio Part 2 (MP3),
Slides (PDF)
Clinical Trials of AVI–4658 and the commercial prospects for a DMD franchise
Dr. Leslie Hudson
Audio (MP3),
Slides (PDF)
Directed alternative splicing mediated by novel oligomers with increased potency and bioavailability
Dr. Ryszard Kole, SVP of Discovery Research, AVI BioPharma
Audio (MP3),
Slides (PDF)
Developing a breakthrough drug–eluting stent (DES) technology using the GTX platform and an improved application of antisense therapy: AVI–5126
Benjamin D. Johnson, Engineering Manager, Global Therapeutics, a COOK Medical Company
Audio (MP3),
Slides (PDF)
Biodefense priorities for AVI and the enablement of HCV drug discovery
Dr. Patrick Iversen, SVP of Strategic Alliances, AVI BioPharma
Audio Part 1 (MP3),
Audio Part 2 (MP3),
Slides (PDF)
Building an RNA–based drug discovery and development company
J. David Boyle, SVP Finance and CFO, AVI BioPharma
Audio (MP3),
Slides (PDF)